Neurocrine Biosciences (NBIX) EPS (Basic) (2016 - 2021)
Historic EPS (Basic) for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $0.24.
- Neurocrine Biosciences' EPS (Basic) rose 13870.97% to $0.24 in Q3 2021 from the same period last year, while for Sep 2021 it was $4.75, marking a year-over-year increase of 37029.7%. This contributed to the annual value of $4.38 for FY2020, which is 99109.48% up from last year.
- As of Q3 2021, Neurocrine Biosciences' EPS (Basic) stood at $0.24, which was up 13870.97% from $0.45 recorded in Q2 2021.
- Neurocrine Biosciences' 5-year EPS (Basic) high stood at $3.72 for Q4 2020, and its period low was -$1.12 during Q1 2019.
- In the last 5 years, Neurocrine Biosciences' EPS (Basic) had a median value of $0.24 in 2021 and averaged $0.23.
- Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 28691.5% in 2017, then skyrocketed by 90842.06% in 2020.
- Quarter analysis of 5 years shows Neurocrine Biosciences' EPS (Basic) stood at $0.08 in 2017, then soared by 168.17% to $0.21 in 2018, then soared by 76.92% to $0.37 in 2019, then surged by 908.42% to $3.72 in 2020, then crashed by 93.55% to $0.24 in 2021.
- Its EPS (Basic) stands at $0.24 for Q3 2021, versus $0.45 for Q2 2021 and $0.34 for Q1 2021.